Yhb Investment Advisors, Inc. Charles River Laboratories International, Inc. Transaction History

Yhb Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 14, 2024	BUY	$203.52 - $273.43 $191,512 - $257,297	941 New	941 $254,000
Q4 2023 Jan 29, 2024	SELL	$164.52 - $238.84 $16,616 - $24,122	-101 Reduced 9.69%	941 $222,000
Q3 2023 Oct 23, 2023	BUY	$194.44 - $217.61 $1,361 - $1,523	7 Added 0.68%	1,042 $204,000
Q3 2022 Nov 03, 2022	BUY	$182.44 - $250.54 $188,825 - $259,308	1,035 New	1,035 $204,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.84B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Yhb Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Yhb Investment Advisors, Inc. with notifications on news.